MiniMed
This article was originally published in The Gray Sheet
Executive Summary
Nets $141.2 mil. from a secondary offering of approximately 2.6 mil. shares of common stock at $68.375 each, including overallotment shares. The infusion system maker had planned an offering of 2.3 mil. shares, including 300,000 shares offered by a selling shareholder (1"The Gray Sheet" July 5, p. 26). Overallotment shares included 172,500 purchased from the company and 172,500 shares from a selling stockholder. The deal was underwritten by Warburg Dillon Read LLC. Co-managers of the offering included Hambrecht & Quist LLC, ING Baring Furman Selz LLC and Volpe Brown Whelan & Company